2017
DOI: 10.5551/jat.rv16007
|View full text |Cite
|
Sign up to set email alerts
|

Transporters for the Intestinal Absorption of Cholesterol, Vitamin E, and Vitamin K

Abstract: Humans cannot synthesize fat-soluble vitamins such as vitamin E and vitamin K. For this reason, they must be obtained from the diet via intestinal absorption. As the deficiency or excess of these vitamins has been reported to cause several types of diseases and disorders in humans, the intestinal absorption of these nutrients must be properly regulated to ensure good health. However, the mechanism of their intestinal absorption remains poorly understood. Recent studies on cholesterol using genome-edited mice, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
32
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 55 publications
(37 citation statements)
references
References 81 publications
2
32
0
Order By: Relevance
“…[18,19,29] Recent studies have shown that ezetimibe efficiently reduces the absorption of dietary and biliary cholesterol in the proximal jejunum and inhibits the transport of serum cholesterol to liver by binding to Niemann-Pick C1-like 1 (NPCL1) sterol transporter in the enterocyte brush border membrane and hepatocyte canalicular membrane. [36,37] In humans, NPCL1 protein is expressed predominantly in the liver and to a lesser extent in the intestine. [19] Thus, the heretofore demonstrated anti-steatosis activity of ezetimibe plus the results of the present meta-analysis underscore the promise of ezetimibe for ameliorating hepatic steatosis.…”
Section: Discussionmentioning
confidence: 99%
“…[18,19,29] Recent studies have shown that ezetimibe efficiently reduces the absorption of dietary and biliary cholesterol in the proximal jejunum and inhibits the transport of serum cholesterol to liver by binding to Niemann-Pick C1-like 1 (NPCL1) sterol transporter in the enterocyte brush border membrane and hepatocyte canalicular membrane. [36,37] In humans, NPCL1 protein is expressed predominantly in the liver and to a lesser extent in the intestine. [19] Thus, the heretofore demonstrated anti-steatosis activity of ezetimibe plus the results of the present meta-analysis underscore the promise of ezetimibe for ameliorating hepatic steatosis.…”
Section: Discussionmentioning
confidence: 99%
“…[ 153,154 ] Although these vitamins can be obtained from the diet, the presence of specific transporters for these vitamins in colonocytes suggests an important role for gut microbes to regulate vitamin availability during homeostasis. [ 153,155 ] The effect of gut microbiota‐derived vitamins on cellular growth is universally accepted; [ 153 ] nevertheless, only a handful of studies have focused on their role on intestinal stem cells. Bashir et al.…”
Section: Gut Microbial Metabolites and Intestinal Stem Cell Activitiesmentioning
confidence: 99%
“…Following food intake, the GB bile is released into the duodenum. Together with dietary cholesterol, biliary cholesterol is absorbed by the enterocytes through sterol transporters such as Niemann‐Pick C1 Like 1, cluster of differentiation 36, scavenger receptor class B type I, and ATP‐binding cassette transporter A1 . Genetic polymorphisms of genes encoding these transporters could therefore disturb the delicate balance between cholesterol secretion and absorption, resulting in gallstone formation and metabolic dysregulation .…”
Section: Gb In Systemic Metabolic Regulationmentioning
confidence: 99%